ArticleCureus2020

The Utility of Oncotype DX for Adjuvant Chemotherapy Treatment Decisions in Estrogen Receptor-positive, Human Epidermal Growth Factor Receptor 2-negative, Node-negative Breast Cancer.

Hirah Rizki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.